E. A. Lyons

发表

The Research on Adverse Drug Events and Reports (RADAR) project.

Matthew H Samore, Jonathan R Nebeker, Kenneth R Carson, 2005, JAMA.

Containerless vitrification of mammalian oocytes and embryos

B. Bavister, K. Forest, E. A. Lyons, 1999, Nature Biotechnology.

Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.

M. Wolf, C. Bennett, R. Durazo-Arvizu, 2006, Urology.

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.

S. Belknap, P. Yarnold, A. Nissenson, 2005, Blood.

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

S. Singhal, J. Mehta, P. Yarnold, 2004 .

Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies: Are Policy Changes Needed?.

S. Belknap, C. Bennett, J. Mckoy, 2004 .

Gemtuzumab ozogamicin (GO)-associated veno-occlusive disease (VOD): An analysis of adverse drug reaction (ADR) reports in the clinical trials, clinical practice, and in the medical literature

P. Yarnold, C. Bennett, J. Mckoy, 2004 .

Report card for accelerated FDA approval oncology drugs (1995- 2003): Is it time for a make-up test?

S. Belknap, C. Bennett, J. Mckoy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EVALUATION OF THE APPROPRIATENESS OF INTRAVENOUS (IV) PHENYTOIN (PHT) IN THE EMERGENCY DEPARTMENT

J. Gonzales, W. Coplin, D. Rhoney, 1998 .

Cryopreservation reduces the ability of hamster 2-cell embryos to regulate intracellular pH.

B. Bavister, E. A. Lyons, Elizabeth A. Lyons, 2000, Human reproduction.

Pure red-cell aplasia and epoetin therapy.

Allen R Nissenson, Stefano Luminari, Benjamin Kim, 2004, The New England journal of medicine.

Clinical features and correlates of gemcitabine‐associated lung injury

S. Belknap, P. Yarnold, T. Kuzel, 2006, Cancer.

Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.

M. Wolf, C. Bennett, J. Mckoy, 2005, Clinical prostate cancer.

Race and literacy effects on prostate cancer biology and access.

M. Wolf, R. Golub, C. Bennett, 2004, Journal of Clinical Oncology.

Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.

Jonathan R Nebeker, Oliver Sartor, Dennis W Raisch, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

and Reports (RADAR) Project epoetin: a follow-up report from the Research on Adverse Drug Events antierythropoietin antibodies in patients treated with recombinant Long-term outcome of individuals with pure red cell aplasia and

S. Belknap, P. Yarnold, A. Nissenson, 2013 .

Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Steven Hirschfeld, Jonathan R Nebeker, Kenneth R Carson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Black box warning on lenalidomide-associated venous thromboembolism (VTE) in off-label setting: A preemptive and unusual safety initiative.

S. Singhal, J. Mehta, P. Yarnold, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.